The insulin-like growth factor I (IGF-I) is one of the main mitogens and anti-apoptotic factors, which has an important role in cell proliferation, inhibiting cell death in prostate cancer (PCa), and may act as a replacement for androgen after castration. Characterizing the changes in local IGF-I levels in the prostate after castration, is therefore of great importance for doctors to guide and select therapy models after surgical castration in men with PCa. The present study was performed to detect IGF-I of local ventral prostate (VP) at intervals up to 24 weeks after castration by a combination of reverse transcriptase PCR, western-blot, immunohistochemistry and immunofluorescence. We found IGF-I to be decreased sharply after castration and that mRNA and protein levels reached their minimum at 2 days and 5 days, respectively. The level of IGF-I increased gradually and although mRNA levels remained high for longer than 2 weeks, protein levels remained high for longer than 4 weeks. The epithelium cells of VP express IGF-I and its receptor longer than 2 weeks after castration. These findings suggested that although IGF-I of local VP decreases sharply in short-stage castration, its levels increase gradually and remain at high levels at least until 24 weeks. IGF-I synthesized mainly from epithelial cells, which may function through the autocrine system longer than 2 weeks castration.
Introduction
The prostate highly depends on androgens for its growth, development and functioning. Castration therapies aim at blocking signaling through the androgen receptor (AR), cause atrophy and epithelium cell loss of prostate. However, castration could not result in all the epithelium cell death or apoptosis, some prostate epithelial could escape the control of androgen, and survive in long-term castration. 1, 2 These facts indicated that the function activity of AR may be affected by other signals including peptide growth factors.
The insulin-like growth factor-I (IGF-I) is one of the growth factors, which has an important role in cell proliferation as an anti-apoptotic factor in prostate tissues. [3] [4] [5] [6] IGF-I can directly activate AR, 7, 8 or enhance AR nuclear translocation in the absence of androgens, 9 indicating that it may act as a replacement for androgen after castration. In addition, maintenance of stroma IGF-I synthesis may result in limiting tumor cell death after castration therapy. 10 These findings indicated that IGF-I may be related to maintaining the prostate epithelium after castration. Many studies were performed to explore IGF-I levels after castration, and found its levels decreased within 2 weeks castration. [11] [12] [13] However, little is known about the changes of IGF-I levels in long-term castration. Understanding the changes in IGF-I after castration therefore has important clinical significance for exploring the relationship between IGF-I and prostate epithelium, and selecting therapy models after surgical castration in prostate cancer (PCa).
Epithelial-stromal interactions has a substantial role in normal prostatic morphogenesis, neoplastic tissue formation. 3, 14 IGF-I, one of the epithelial-stromal interaction factors, promotes prostate epithelial proliferation and anti-apoptosis through paracrine or autocrine way and is principally synthesized in prostate stroma or in the epithelium, or in both of these tissue compartments. [15] [16] [17] Previous study reported that IGF-I is synthesized mainly by stroma in short-stage castration, and may have a role through paracrine or autocrine way; 11 however, the sites of IGF-1 production in long-term castration (up to 24 weeks) is still unknown.
In this study, we used rat castration model to detect the IGF-I levels of ventral prostate (VP) at intervals up to 24 weeks after castration in order to better understand changes in its levels after castration. Additionally, we sought to explore the location of IGF-1 and IGF-I receptor (IGF-IR) to find out the mode of action of IGF-I. Tissue fixation, hematoxylin and eosin staining, immunohistochemistry and immunofluorescence Anesthetized rats were perfused transcardially with 4% paraformaldehyde in phosphate-buffered saline. Then VP tissues were post fixed and embedded in paraffin. VP lobes were sliced (4 mm thickness). For hematoxylin and eosin staining, the sections were stained with hematoxylin and eosin for general histology.
Materials and methods

Animals
For immunohistochemistry, sections were blocked for 1 h at room temperature with normal goat serum, and incubated overnight at 4 1C with primary antibody against IGF-I (1:150, rabbit anti-rat, Santa Cruz Biotechnology, Santa Cruz, CA, USA), AR (1:150, rabbit anti-rat, Abnova, Taipei, Taiwan), IGF-IR (1:150, rabbit anti-rat, Bioworld Technology, Louis Park, MN, USA) or Epithelium specific antigen (Ep-CAM/ESA) (1:150, mouse anti-rat, Santa Cruz) in Tris-buffered saline (TBS) plus 1% bovine serum albumin. After rinsing with TBS plus 0.1% Tween 20 (TTBS), tissues were incubated for 1 h at room temperature with secondary antibody, goat anti-rabbit immunoglobulin G biotinylated antibody (1:200, Santa Cruz) for IGF-I and IGF-IR, or goat anti-mouse immunoglobulin G biotinylated antibody (1:200, Santa Cruz) for Ep-CAM/ESA. After rinsing with TTBS, tissues were incubated in streptavidinhorseradish-peroxidase complexes for 1 h at room temperature. Tissues were further washed with TTBS, and color development was achieved by incubation for 10 min in 3-3 0 diaminobenzidine tetrachloride (DAB, Santa Cruz). The reaction was stopped by washing the tissue with tap water, followed by distilled water. Tissues were observed under a labophot-2 microscope with white light illumination (OLYMPUS, Tokyo, Japan).
For immunofluorescence, tissues sections were blocked with 10% goat serum and incubated with antibody against IGF-I (1:150, rabbit anti-rat, Santa Cruz) or IGF-IR (1:150, rabbit anti-rat, Bioworld Technology) and with antibody against Ep-CAM/ESA (epithelium marker, 1:150, mice anti-rat, Santa Cruz). Immunofluorescence was revealed using FITC-labeled fragments of goat anti-rabbit immunoglobulin G plus TRITC-labeled fragments of goat antimouse immunoglobulin G (1:200, Santa Cruz). Tissue sections were mounted in 50% glycerol dissolved in 0.01 m phosphate-buffered saline. Samples were observed under a confocal microscope equipped with argon and helio/neon lasers (Leica TCS SP2, Wetzlar, Germany). Controls were performed by omitting either one or both primary antibodies. All controls gave negative results with no detectable labeling.
Reverse transcriptase PCR analysis
Total RNA was extracted from rat VP lobes using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. RNA concentrations were determined by using a ND-100 Spectrophotometer (NanoDrop, Wilmington, DE, USA), and RNA integrity was ensured by separating the samples with 0.8% agarose gel electrophoresis.
The complementary DNAs were obtained from reverse transcription of 1000 ng RNA by superscript II RNase H reverse transcriptase with Oligo (dT) primer (Takara, Ostushiga, Japan). The synthesized complementary DNA (1 ml) was used as a template to amplify by PCR according to the manufacturer's protocol (Takara). The primer sequences used are presented in Table 1 .
The amplification program we used was as follows: denaturation at 95 1C for 5 min; followed by 35 cycles of denaturing at 94 1C for 30 s, annealing for 30 s (55 1C for IGF-I, 63 1C for IGF-IR) at the indicated temperature, and extension at 72 1C for 30 s. The PCR reaction was completed by an additional extension reaction at 72 1C for 7 min before termination. After amplification, the PCR products were separated by electrophoresis on 2% agarose gels containing 0.005% ethidium bromide visualized by ultraviolet light. Band intensities were estimated by densitometric scanning using a GelDoc scanner (Bio-Rad, Hercules, CA, USA) and the resulting data was quantified by calculating a ratio of IGF-I to b-actin mRNA. Abbreviations: IGF-I, insulin-like growth factor I; IGF-IR, insulin-like growth factor I receptor.
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Western blot analysis
Tissue specimens were homogenized at 4 1C in a homogenization buffer containing 50 mM EDTA, 2 mg ml À1 leupeptin, 2 mg ml À1 pepstatin A, 2 mM phenylmethysufonyl fluoride and 200 KIE/ml aprotinin. The homogenates were then centrifuged at 10 000g for 20 min at 4 1C. The supernatant was collected and protein concentration was determined by a Bradford assay kit (Bio-Rad). Samples were separated by 12% SDS-polyacrylamide gel electrophoresis gel, and then transferred onto polyvinylidene difluoride membrane at 250 mA 1.5 h for IGF-1 and 350 mA 55 min for b-actin. Blotted membranes were blocked with 5% skim milk and then incubated with primary antibody against IGF-I (1:1000, rabbit anti-IGF-I, Santa Cruz) or b-actin (1:5000, Abcam, Cambridge, UK). Thereafter, they were incubated with horse radish peroxidase-conjugated secondary antibodies (1:5000, Santa Cruz). The optical densities of IGF-I and b-actin bands were quantitatively analyzed by gel densitometry (Bio-Rad). The specific reaction was visualized by using a chemiluminescent substrate (Pierce Biotechnology, Rockford, IL, USA). The bands were quantified by gel densitometry and the value of individual IGF-I protein (17 kD) band was divided by the value for b-actin (42 kD) band for the same sample to calculate a ratio of IGF-I to b-actin for each sample.
Statistical analysis
Statistical analyses were performed using Statistical Package for Student Software (SPSS 10.0, IBM, New York, NY, USA). All values were expressed as the mean ± s.d. and the statistical differences in IGF-I levels between normal and test group or sham-operated group at each time point were determined by the Mann-Whitney U-test. Statistical differences among sham-operated groups were determined by KruskalWallis test. The results were considered significantly different with a two-sided Pp0.05.
Results
The VP weight result after castration
In normal group, the VP lobe weight was B0.108 ± 0.015% of the animal's body weight. There was no significant difference of VP weight between sham-operated group and normal group. In test group, however, the weight of VP was drastically reduced to about 0.06±0.012% of the animal's body weight at 5 days after castration. VP weight then remained at about 0.02% of the animal's body weight from 2 weeks to 24 weeks after castration in the test group. VP weight decreased by 44.7% within 5 days after castration (Figure 1 ) but there was no significant difference in VP weight from 10 days to 24 weeks after castration (P ¼ 0.058).
Morphological examination and EP-CAM/ESA expression of VP lobes after castration
After castration, VP lobes of test group were atrophic compared with sham-operated group. According to the hematoxylin and eosin staining, the structure of VP became smaller and larger magnification was needed to notice the relevant structures (Figures 2a and b) . Longer than 4 weeks after castration, a gland-like structure with a thick wall appeared (Figure 2c) , and the location of epithelium in the thick-walled gland became difficult to determine. To identify whether prostate epithelium cells survived longer than 4 weeks after castration, we stained the VP with antibodies against epithelium-specific antigen (EP-CAM/ESA). We found that some cells expressed EP-CAM/ESA in VP samples range from 1 day to 24 weeks after castration and were located in the inner ring of the VP gland (Figure 2i ).
The changes of expression of IGF-I, AR and IGF-IR in VP after castration
The distribution of IGF-I/IGF-IR protein in VP lobes after castration was examined by immunohistochemical and immunofluorescence techniques. The expression of IGF-I/IGF-IR in sham-operated group and normal group was similar among different time points. IGF-I was located mainly in the cytoplasm of stromal cells, whereas IGF-IR was mainly expressed in the membrane of VP epithelium cells (Figure 2d ).
In the test group, IGF-I was expressed mainly in the cytoplasm of stromal cells within 3 days after castration (Figures 2e and f) . However, the expression of IGF-I was almost undetectable by immunohistochemistry and immunofluorescence at 5 days after castration. At 2 weeks after castration, the expression of IGF-I reappeared and was almost located in the epithelium cells from 2 weeks to 24 weeks after castration ( Figures  2g, m-o) . Castration did not affect the distribution or intensity of IGF-IR expression, it was mainly expressed in the membrane of VP epithelium cells (Figures 2j-l) .
AR immunochemistry results showed it located in the nucleus of epithelium of VP both in normal and castrated rat (Figure 2h ).
Changes in IGF-I and IGF-IR mRNA levels in VP after castration
After castration, there was no significant change in the level of IGF-IR mRNA among different time points (Figure 3, P ¼ 0.101) . In the test group, castration resulted 
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in decrease in IGF-I mRNA levels. IGF-I mRNA levels dropped sharply within 2 days after castration (P ¼ 0.002), then increased gradually from 2 days to 2 weeks after castration. IGF-I mRNA levels were maintained at a high level longer than 2 weeks after castration (Figure 4a ). In the sham-operated group, IGF-I mRNA levels did not change significantly at any time points (Figure 4b, P ¼ 0.473) .
Changes in IGF-I protein levels in VP after castration
In the test group, IGF-I protein levels decreased rapidly within 5 days after castration, reaching undetectable levels on the fifth day. IGF-I protein levels increased gradually from 7 days to 4 weeks after castration, and remained at a high level from 4 to 24 weeks after castration (Figure 4c ). In the sham-operated group, IGF-I protein levels remained unchanged at all time points (Figure 4d, P ¼ 0.662) . 
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Discussion
Castration is the first choice in treatment of advanced PCa. 18 Several early effects of castration in prostate were related to the IGF-I system. 11 Previous studies have mainly characterized IGF-I levels and the relationship between IGF-I and prostate involution or prostate epithelial cell apoptosis within 2 weeks after castration .11-13 However, changes of IGF-I in long-term castration was poorly understood. In this study, we examined changes in IGF-I levels, the site of IGF-I production and mode of its action up to 24 weeks after castration.
Castration could result in atrophy and epithelium cell loss of VP. However, some evidences indicate that epithelium cells are not lost even in long-term castration. 1, 2 In order to identify whether prostate epithelium cells indeed persist after long-term castration, we used EP-CAM/ESA, an epithelium cell specific marker, to detect epithelium cells. We found EP-CAM/ESA was expressed in some cells of VP ranging from 1 day to 24 weeks after castration, confirming that epithelium cells persist even after long-term castration.
In present study, we found that IGF-I levels decreased sharply after castration, reaching minimum levels at 2 days for mRNA and 5 days for protein after castration; castration resulted in about 44.7% weight reduction of VP within 5 days. Decreased IGF-I levels may mediate some of the key features of castration-induced prostate involution in Figure 3 Changes in insulin-like growth factor I receptor (IGF-IR) mRNA levels in ventral prostate. After castration, the IGF-IR mRNA levels did not change significantly at any time points (P ¼ 0.101, using Kruskal-Wallis test). Cast, castration after; Nor, normal. Significantly different from normal group (Po0.05, using Mann-Whitney U-test). In sham-operated group, the IGF-I mRNA and protein levels had no significant change from normal group (P40.05, using Mann-Whitney U-test) or among each time point (P ¼ 0.473 for mRNA and P ¼ 0.662 for protein, using Kruskal-Wallis test). Cast, castration after; Nor, normal.
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11 Since IGF-I could stimulate VEGF synthesis in prostate epithelial cells and increase vascular density in VP, 11, 19, 20 the reduction of its level could decrease blood flow that may be an important reason for epithelial cell apoptosis and subsequent glandular involution in VP. 21, 22 In addition, androgen levels have been reported to be decreased in short-term castration. 23 Taken together with our findings that IGF-1 levels decrease in short-term castration, it is possible that androgen regulates IGF-I synthesis and this regulation may underlie the reduction in IGF-1 levels observed in short-term castration. 10 Although IGF-I levels decreased in the short-stage castration, its levels eventually increased over time. Elevated IGF-I levels were found to be maintained up to 24 weeks after castration in present study. What could be the consequence of such elevated levels of IGF-1 after castration? First, increased IGF-I may act as a substitute for androgen after castration, it can directly activate the AR, or enhance AR nuclear translocation. [7] [8] [9] Second, the increased IGF-I could bind to IGF-IR and activate downstream signal cascades (PI3K/AKT cascade) to increase prostate cell growth and proliferation. 24, 25 IGF-I levels may be age-dependent. 3, 26, 27 To exclude the influence of age, we detected the IGF-I protein/ mRNA levels of sham-operated rats and did not obtain the same results. Our study found there was no statistical difference among different time points in the shamoperated group, suggesting that the changes of IGF-I levels in test group was not caused by age, which ranged 3 months to 9 months. The differences in relationship of IGF-I and age between our study and previous studies might be due to the use of different species or different time points or detecting different IGF-I type.
The biological responses of IGF-I are mediated primarily by IGF-IR, a tyrosine kinase receptor at the cell surface. 24 In present study, IGF-IR levels did not change significantly at any time point after castration, indicating its levels were not affected by castration.
In present study, within 5 days after castration, IGF-I was synthesized mainly in prostatic stroma, whereas its receptor (IGF-IR) was expressed by epithelial cells. Therefore, stromally secreted IGF-I may promote epithelial proliferation mainly through the paracrine way. From 2 to 24 weeks after castration, however, the IGF-I acts in autocrine way, as the epithelium cells could express both IGF-I and its receptor, indicating that epithelium cells grow independent of stromal cells. These results suggested that the site of IGF-I may vary at different stage after castration; other studies also proved that the IGF-I synthesis may be different in certain circumstance and vary in different species. [15] [16] [17] In conclusion, we report here that although IGF-I of local VP decreases sharply in short-stage castration, its levels increase gradually and remain at high levels at least until 24 weeks after castration. IGF-I may act as a replacement for androgen by autocrine methods in the case of long-term castration. Therefore, inhibition of IGF-I in combination with castration (or androgen deprivation) may offer an effective therapeutic approach for PCa or even for androgen-independent PCa.
